Deal date

KANDO id: 1048592

Financial Transaction:

Series D


Lyra Health


Currency
United States Dollar
Value in original currency
110,000,000
Company valuation (pre money)
990,000,000
Value in USD
110,000,000
Company valuation in USD (pre money)
990,000,000

Lead investor

Country Notes

Addition

United States

Round participants

Country Notes

Casdin Capital

Counterpart Advisors

Glynn Capital Management LLC

Private and public technology investment firm.
United States

Greylock Partners

Venture capital firm.
United States

Institutional Venture Partners

(IVP)
US-based venture capital investment firm focusing on later-stage companies and growth equity investments.
United States

MeriTech Capital Partners

Venture firm focused on late-stage investments in consumer Internet and media, software and services, enterprise infrastructure, medical devices.
United States

Tenaya Capital Inc

VC firm providing early-growth stage capital to transformational venture-backed technology businesses.
United States

Howard Schultz

Individual investor.